PT - JOURNAL ARTICLE AU - Hong, Pei-Ying AU - Rachmadi, Andri Taruna AU - Mantilla-Calderon, David AU - Alkahtani, Mohsen AU - Bashwari, Yasir M. AU - Al Qarni, Hamed AU - Zhou, Jianqiang TI - How early into the outbreak can surveillance of SARS-CoV-2 in wastewater tell us? AID - 10.1101/2020.08.19.20177667 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.19.20177667 4099 - http://medrxiv.org/content/early/2020/08/22/2020.08.19.20177667.short 4100 - http://medrxiv.org/content/early/2020/08/22/2020.08.19.20177667.full AB - There is increasing interest to use wastewater-based surveillance of SARS-CoV-2 as an early warning of the outbreak within a community. Despite successful detection of SARS-CoV-2 in wastewaters sampled from multiple locations, there is still no clear idea on the minimal number of cases needed in a community to result in a positive detection of the virus in wastewaters. To address this knowledge gap, we sampled wastewaters from a septic tank and biological activated sludge tank located on-site of a hospital. The hospital is providing treatment for SARS-CoV-2 infected patients, with the number of hospitalized patients per day known. It was observed that > 253 positive cases out of 10,000 persons are required prior to detecting SARS-CoV-2 in wastewater. There was a weak correlation between N1 and N2 gene abundances in wastewater with the number of hospitalized cases. This correlation was however not observed for N3 gene. The occurrence frequency of SARS-CoV-2 is at least 5 times lower in the partially treated wastewater than in the septic tank. Furthermore, abundance of N1 and N3 genes in the activated sludge tank were 50 and 70% of the levels detected in septic tank, suggesting poor persistence of the SARS-CoV-2 gene fragments in wastewater.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study only sampled wastewater and does not involve any clinical trials.Funding StatementThis study is funded by KAUST Baseline funding BAS/1/1033-01-01 awarded to Peiying HongAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:King Abdullah University of Science and Technology Institutional Biosafety and Bioethics Committtee has provide approval for the research described involving wastewater sampling and monitoring.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are included and additional data can be requested from corresponding author.